In addition, studies on hybrid nanoparticles enhanced with hyaluronic acid for delivering an HSP90 inhibitor emphasize their potential in targeted cancer therapy by enhancing drug delivery efficiency and specificity (Pan et al., 2021). The gene discussed is HSP90AA1; the disease is cancer.